| Drugs by Condition |  |
Pancreatic Cancer Medications
Definition of Pancreatic Cancer: Pancreatic carcinoma is a malignancy (cancer) of the pancreas.
Drugs associated with Pancreatic Cancer
The following drugs and medications are in some way related to, or used in the treatment of Pancreatic Cancer.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|---|---|---|
Adrucil (More...) generic name: fluorouracil class: antimetabolites | 0 Review(s) | Not rated - Be the first |
| Gemzar (Pro, More...)generic name: gemcitabine class: antimetabolites | 0 Review(s) | Not rated - Be the first |
| Mutamycin (Pro, More...)generic name: mitomycin class: antibiotics/antineoplastics | 0 Review(s) | Not rated - Be the first |
| Tarceva (Pro, More...)generic name: erlotinib class: tyrosine kinase inhibitors | 0 Review(s) | Not rated - Be the first |
| Zanosar (Pro, More...)generic name: streptozocin class: alkylating agents | 0 Review(s) | Not rated - Be the first |
Pancreatic Cancer Medications in the Pipeline
Virulizin
Orathecin (rubitecan)
- January 3, 2005
SuperGen Announces Withdrawal of Orathecin NDA - November 29, 2004
SuperGen Announces 90 Day Extension of FDA Review Date for Orathecin New Drug Application - March 26, 2004
SuperGen’s New Drug Application for Orathecin (rubitecan) capsules accepted by FDA for filing - March 26, 2004
SuperGen’s New Drug Application for Orathecin (rubitecan) capsules accepted by FDA for filing - January 28, 2004
SuperGen completes submission of New Drug Application (NDA) for Orathecin as an oral treatment for pancreatic cancer
